source
- Vera's IgAN approval kicks off competition with OtsukaVera Therapeutics’ fusion protein atacicept got an accelerated approval on Tuesday for a chronic autoimmune disease that damages the kidneys. The drug will be marketed as Trutakna for immunoglobuli…Endpoints · 23d ago↗ source
- STAT+: FDA approves Vera Therapeutics kidney disease treatmentThe FDA approved a new medicine from the biotech company Vera Therapeutics for patients with a type of chronic autoimmune kidney disease.STAT · 23d ago↗ source
- Oberland pours up to $400M into MeiraGTx eye gene therapiesThe funding deal is a vote of confidence in the sales potential of multiple prospects in late-stage development — one of which MeiraGTx recently reacquired from J&J.BioPharma Dive · 23d ago